Search Results

There are 2708 results for: content related to: Tamsulosin reduces nighttime urine production in benign prostatic hyperplasia patients with nocturnal polyuria: A prospective open-label long-term study using frequency–volume chart

  1. You have free access to this content
    Interaction between udenafil and tamsulosin in rats: non-competitive inhibition of tamsulosin metabolism by udenafil via hepatic CYP3A1/2

    British Journal of Pharmacology

    Volume 156, Issue 6, March 2009, Pages: 1009–1018, HE Kang, SK Bae, M Yoo, DC Lee, YG Kim and MG Lee

    Version of Record online : 27 FEB 2009, DOI: 10.1111/j.1476-5381.2008.00099.x

  2. You have free access to this content
    Efficacy and tolerability of tamsulosin 0.4 mg in Asian patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia refractory to tamsulosin 0.2 mg: A randomized placebo controlled trial

    International Journal of Urology

    Volume 21, Issue 7, July 2014, Pages: 677–682, Jung Jun Kim, Deok Hyun Han, Hyun Hwan Sung, Seol Ho Choo and Sung Won Lee

    Version of Record online : 13 APR 2014, DOI: 10.1111/iju.12412

  3. Tadalafil Enhances the Inhibitory Effects of Tamsulosin on Neurogenic Contractions of Human Prostate and Bladder Neck

    The Journal of Sexual Medicine

    Volume 9, Issue 9, September 2012, Pages: 2293–2306, Javier Angulo, Pedro Cuevas, Argentina Fernández, José M. La Fuente, Antonio Allona, Ignacio Moncada and Iñigo Sáenz de Tejada

    Version of Record online : 3 JUL 2012, DOI: 10.1111/j.1743-6109.2012.02821.x

  4. You have free access to this content
    Effects of strong CYP2D6 and 3A4 inhibitors, paroxetine and ketoconazole, on the pharmacokinetics and cardiovascular safety of tamsulosin

    British Journal of Clinical Pharmacology

    Volume 72, Issue 2, August 2011, Pages: 247–256, Joachim Troost, Shinji Tatami, Yasuhiro Tsuda, Michaela Mattheus, Ludwig Mehlburger, Martina Wein and Martin C. Michel

    Version of Record online : 11 JUL 2011, DOI: 10.1111/j.1365-2125.2011.03988.x

  5. Effect of Dapoxetine on the Pharmacokinetics and Hemodynamic Effects of Tamsulosin in Men on a Stable Dose of Tamsulosin

    The Journal of Clinical Pharmacology

    Volume 48, Issue 12, December 2008, Pages: 1438–1450, Dr N. B. Modi, Dr S. Kell, Dr J. Aquilina and Dr D. Rivas

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270008324695

  6. You have free access to this content
    Non-inferiority of silodosin to tamsulosin in treating patients with lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH)

    BJU International

    Volume 108, Issue 11, December 2011, Pages: 1843–1848, Hong-Jeng Yu, Alex Tong-Long Lin, Stephen Shei-Dei Yang, Ke-Hung Tsui, Hsi-Chin Wu, Chen-Li Cheng, Hong-Lin Cheng, Tony T. Wu and Po-Hui Chiang

    Version of Record online : 18 MAY 2011, DOI: 10.1111/j.1464-410X.2011.10233.x

  7. Antagonistic activity of tamsulosin against human vascular α1-adrenergic receptors

    Clinical Pharmacology & Therapeutics

    Volume 67, Issue 4, April 2000, Pages: 405–412, Kazuhiro Harada, Atsuhiro Kawaguchi, Masami Ohmori and Akio Fujimura

    Version of Record online : 11 APR 2000, DOI: 10.1067/mcp.2000.105354

  8. A Comparative Randomized Prospective Study to Evaluate Efficacy and Safety of Combination of Tamsulosin and Tadalafil vs. Tamsulosin or Tadalafil Alone in Patients with Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia

    The Journal of Sexual Medicine

    Volume 11, Issue 1, January 2014, Pages: 187–196, Dig Vijay Singh, Uttam Kumar Mete, Arup Kumar Mandal and Shrawan Kumar Singh

    Version of Record online : 24 OCT 2013, DOI: 10.1111/jsm.12357

  9. You have free access to this content
    Clinical outcomes after combined therapy with dutasteride plus tamsulosin or either monotherapy in men with benign prostatic hyperplasia (BPH) by baseline characteristics: 4-year results from the randomized, double-blind Combination of Avodart and Tamsulosin (CombAT) trial

    BJU International

    Volume 107, Issue 6, March 2011, Pages: 946–954, Claus G. Roehrborn, Jack Barkin, Paul Siami, Andrea Tubaro, Timothy H. Wilson, Betsy B. Morrill and R. Paul Gagnier

    Version of Record online : 18 FEB 2011, DOI: 10.1111/j.1464-410X.2011.10124.x

  10. You have free access to this content
    The effects of tamsulosin, a high affinity antagonist at functional α1A- and α1D-adrenoceptor subtypes

    British Journal of Pharmacology

    Volume 120, Issue 2, January 1997, Pages: 231–238, A J Noble, R Chess-Williams, C Couldwell, K Furukawa, T Uchyiuma, C Korstanje and C R Chapple

    Version of Record online : 3 FEB 2009, DOI: 10.1038/sj.bjp.0700907

  11. You have free access to this content
    Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4-year results of the CombAT study

    BJU International

    Volume 113, Issue 4, April 2014, Pages: 623–635, Claus G. Roehrborn, Jack Barkin, Andrea Tubaro, Mark Emberton, Timothy H. Wilson, Betsy J. Brotherton and Ramiro Castro

    Version of Record online : 9 JAN 2014, DOI: 10.1111/bju.12500

  12. A Randomized, Placebo-Controlled Study to Assess Safety and Efficacy of Vardenafil 10 mg and Tamsulosin 0.4 mg vs. Tamsulosin 0.4 mg Alone in the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia

    The Journal of Sexual Medicine

    Volume 9, Issue 6, June 2012, Pages: 1624–1633, Mauro Gacci, Gianni Vittori, Nicola Tosi, Giampaolo Siena, Mario Alberto Rossetti, Alberto Lapini, Linda Vignozzi, Sergio Serni, Mario Maggi and Marco Carini

    Version of Record online : 17 APR 2012, DOI: 10.1111/j.1743-6109.2012.02718.x

  13. Benign Prostatic Hyperplasia

    Standard Article

    Wiley Handbook of Current and Emerging Drug Therapies

    Published Online : 13 OCT 2006, DOI: 10.1002/9780470041000.cedt065

  14. You have free access to this content
    Effects of Alfuzosin and Tamsulosin on Sperm Parameters in Healthy Men: Results of a Short-Term, Randomized, Double-Blind, Placebo-Controlled, Crossover Study

    Journal of Andrology

    Volume 30, Issue 4, July-August 2009, Pages: 469–474, Wayne J. G. Hellstrom and Suresh C. Sikka

    Version of Record online : 2 JAN 2013, DOI: 10.2164/jandrol.108.006874

  15. You have free access to this content
    The effects of dutasteride or tamsulosin alone and in combination on storage and voiding symptoms in men with lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH): 4-year data from the Combination of Avodart and Tamsulosin (CombAT) study

    BJU International

    Volume 107, Issue 9, May 2011, Pages: 1426–1431, Francesco Montorsi, Claus Roehrborn, Javier Garcia-Penit, Michael Borre, Ton A. Roeleveld, Jean-Charles Alimi, Paul Gagnier and Timothy H. Wilson

    Version of Record online : 23 FEB 2011, DOI: 10.1111/j.1464-410X.2011.10129.x

  16. You have free access to this content
    Efficacy and safety of tamsulosin OCAS

    BJU International

    Volume 98, Issue s2, November 2006, Pages: 13–17, MARK SPEAKMAN

    Version of Record online : 18 SEP 2006, DOI: 10.1111/j.1464-410X.2006.06495.x

  17. You have free access to this content
    Population pharmacokinetics of tamsulosin hydrochloride in paediatric patients with neuropathic and non-neuropathic bladder

    British Journal of Clinical Pharmacology

    Volume 70, Issue 1, July 2010, Pages: 88–101, Yasuhiro Tsuda, Shinji Tatami, Norio Yamamura, Yusuke Tadayasu, Akiko Sarashina, Karl-Heinz Liesenfeld, Alexander Staab, Hans-Günter Schäfer, Ichiro Ieiri and Shun Higuchi

    Version of Record online : 9 MAR 2010, DOI: 10.1111/j.1365-2125.2010.03662.x

  18. You have free access to this content
    Lower urinary tract symptoms suggestive of benign prostatic hyperplasia: latest update on α1-adrenoceptor antagonists

    BJU International

    Volume 95, Issue s4, June 2005, Pages: 29–36, Shirin Milani and Bob Djavan

    Version of Record online : 4 MAY 2005, DOI: 10.1111/j.1464-410X.2005.05485.x

  19. Tadalafil Administered Once Daily for Treatment of Lower Urinary Tract Symptoms in Korean men with Benign Prostatic Hyperplasia: Results from a Placebo-Controlled Pilot Study Using Tamsulosin as an Active Control

    LUTS: Lower Urinary Tract Symptoms

    Volume 3, Issue 2, September 2011, Pages: 86–93, Sae Chul KIM, Jong Kwan PARK, Sae Woong KIM, Sung Won LEE, Tai Young AHN, Je Jong KIM, Jae Seung PAICK, Nam Cheol PARK, Kwangsung PARK, Kweon Sik MIN, Stephen R. KRAUS, Roberta J. SECREST, Albert ELION-MBOUSSA and Lars VIKTRUP

    Version of Record online : 17 APR 2011, DOI: 10.1111/j.1757-5672.2011.00088.x

  20. You have free access to this content
    New clinical evidence of silodosin, an α1A selective adrenoceptor antagonist, in the treatment for lower urinary tract symptoms

    International Journal of Urology

    Volume 19, Issue 4, April 2012, Pages: 306–316, Masaki Yoshida, Junzo Kudoh, Yukio Homma and Kazuki Kawabe

    Version of Record online : 17 JAN 2012, DOI: 10.1111/j.1442-2042.2011.02957.x